Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 1.736
5-Year Impact Factor – 2.135
Index Copernicus  – 168.52
MEiN – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2020, vol. 29, nr 1, January, p. 135–145

doi: 10.17219/acem/104556

Publication type: original article

Language: English

License: Creative Commons Attribution Non-Commercial License

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Vitexin improves neuron apoptosis and memory impairment induced by isoflurane via regulation of miR-409 expression

Yingkai Qi1,A,F, Linlin Chen1,B,C, Shiqiang Shan1,C,D, Yu Nie1,D,E, Yansheng Wang1,E,F

1 Cangzhou Central Hospital, China

Abstract

Background. Anesthetics, such as isoflurane, sevoflurane, ketamine, and desflurane, are commonly used in clinics. Specifically, isoflurane is one of the most commonly used inhalational anesthetics, which can be used in surgery patients of all ages, including children.
Objectives. The aim of the study was to investigate the mechanisms of vitexin against isoflurane-induced neurotoxicity.
Material and Methods. Reference memory testing was performed for 5 days (4 trials, 2 per day) before anesthesia. Reversal testing was performed on the 3rd day after anesthesia. The cell viability and apoptosis of PC-12 cells were detected using MTT and TUNEL assays, respectively. Enzyme-linked immunosorbent assay (ELISA) kits were used to measure serum tumor necrosis factor α (TNF‑α), interleukin 6 (IL‑6), glutathione (GSH), and superoxide dismutase (SOD) concentrations. The concentration of reactive oxygen species (ROS) was detected using ROS measurement. Expression of miR-409 was determined using quantitative reverse-transcription polymerase chain reaction (qPT-PCR). Protein expression levels were detected using western blotting.
Results. Rats treated with isoflurane showed significant increases in the escape latency periods (ELP) and the apoptosis of hippocampus neuron cells; this effect was reversed by 3 mg/kg or 10 mg/kg of vitexin (p < 0.05). Further testing showed that isoflurane could significantly decrease the cell viability and increase the apoptosis of PC-12, the expression of inflammatory cytokines (TNF‑α and IL‑6) and ROS (p < 0.05). However, these results were reversed by 10/100 μM of vitexin. In addition, vitexin could significantly increase the expression of miR-409 (p < 0.05). Further studies showed that overexpression of miR-409 could significantly promote the effect of vitexin on isoflurane-induced neurotoxicity (p < 0.05). Finally, overexpression miR-409 could significantly increase the expression of p-AMPK/t-AMPK and p-GSK3β/t-GSK3β.
Conclusion. Vitexin has protective effects against isoflurane-induced neurotoxicity by targeting miR-409 and the AMPK/GSK3β pathway.

Key words

neurotoxicity, isoflurane, vitexin, miR-409, AMPK/GSK3β signaling pathway

References (51)

  1. Wei H, Liang G, Yang H, et al. The common inhalational anesthetic isoflurane induces apoptosis via activation of inositol 1,4,5-trisphos­phate receptors. Anesthesiology. 2008;108(2):251–260.
  2. Bittner EA, Yue Y, Xie Z. Brief review: Anesthetic neurotoxicity in the elderly, cognitive dysfunction and Alzheimer’s disease. Can J Anaesth. 2011;58(2):216–223.
  3. Jevtovictodorovic V, Hartman RE, Izumi Y, et al. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci. 2003;23(3):876–882.
  4. Culley DJ, Baxter MG, Yukhananov R, Crosby G. Long-term impairment of acquisition of a spatial memory task following isoflurane-nitrous oxide anesthesia in rats. Anesthesiology. 2004;100(2):309–314.
  5. Culley DJ, Baxter M, Yukhananov R, Crosby G. The memory effects of general anesthesia persist for weeks in young and aged rats. Anesth Analg. 2003;96(4):1004–1009.
  6. Abildstrom H, Rasmussen LS, Rentowl P, et al. Cognitive dysfunction 1–2 years after non-cardiac surgery in the elderly. ISPOCD group. International Study of Post-Operative Cognitive Dysfunction. Acta Anaesthesiol Scand. 2000;44(10):1246–1251.
  7. Wilder RT, Flick RP, Sprung J, et al. Early exposure to anesthesia and learning disabilities in a population-based birth cohort. Anesthesio­logy. 2009;110(4):796–804.
  8. Spencer JP. The interactions of flavonoids within neuronal signaling pathways. Genes Nutr. 2007;2(3):257–273.
  9. Commenges D, Scotet V, Renaud S, Jacqmingadda H, Barbergergateau P, Dartigues JF. Intake of flavonoids and risk of dementia. Eur J Epidemiol. 2000;16(4):357–363.
  10. Kim JY, Lee WS, Kim YS, et al. Isolation of cholinesterase-inhibiting flavonoids from Morus lhou. J Agric Food Chem. 2011;59(9):4589–4596.
  11. Uriarte-Pueyo I, Calvo MI. Flavonoids as acetylcholinesterase inhibitors. Curr Med Chem. 2011;18(34):5289–5302.
  12. Agullo G, Gamet-Payrastre L, Manenti S, et al. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: A comparison with tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol. 1997;53(11):1649–1657.
  13. Gametpayrastre L, Manenti S, Gratacap MP, Tulliez J, Chap H, Payrastre B. Flavonoids and the inhibition of PKC and PI 3-kinase. Gen Pharmacol. 1999;32(3):279–286.
  14. Kong AN, Yu R, Chen C, Mandlekar S, Primiano T. Signal transduction events elicited by natural products: Role of MAPK and caspase pathways in homeostatic response and induction of apoptosis. Arch Pharm Res. 2000;23(1):1–16.
  15. Schroeter H, Spencer JP, Riceevans C, Williams RJ. Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3. Biochem J. 2001;358(Pt 3):547–557.
  16. Kobuchi H, Roy S, Sen CK, Nguyen HG, Packer L. Quercetin inhibits inducible ICAM-1 expression in human endothelial cells through the JNK pathway. Am J Physiol. 1999;277(3):C403–411.
  17. Mielke K, Herdegen T. JNK and p38 stresskinases: Degenerative effectors of signal-transduction-cascades in the nervous system. Prog Neurobiol. 2000;61(1):45–60.
  18. Chen L, Zhang B, Shan S, Zhao X. Neuroprotective effects of ­vitexin against isoflurane-induced neurotoxicity by targeting the TRPV1 and NR2B signaling pathways. Mol Med Rep. 2016;14(6):5607–5613.
  19. Wang Y, Zhen Y, Wu X, et al. Vitexin protects brain against ischemia/reperfusion injury via modulating mitogen-activated protein kinase and apoptosis signaling in mice. Phytomedicine. 2015;22(3):379–384.
  20. Rosczyk HA, Sparkman NL, Johnson RW. Neuroinflammation and cognitive function in aged mice following minor surgery. Exp Gerontol. 2008;43(9):840–846.
  21. Vorhees CV, Williams MT. Morris water maze: Procedures for assessing spatial and related forms of learning and memory. Nat Protoc. 2006;1(2):848–858.
  22. Kong AN, Yu R, Chen C, Mandlekar S, Primiano T. Signal transduction events elicited by natural products: Role of MAPK and caspase pathways in homeostatic response and induction of apoptosis. Arch Pharm Res. 2000;23(1):1–16.
  23. Liu Z, Huang YY, Wang YX, et al. Prevention of cell death by the zinc ion chelating agent TPEN in cultured PC-12 cells exposed to oxygen–glucose deprivation (OGD). J Trace Elem Med Biol. 2015;31:45–52.
  24. Castagne V, Gautschi M, Lefevre K, Posada A, Clarke PG. Relationships between neuronal death and the cellular redox status: Focus on the developing nervous system. Prog Neurobiol. 1999;59(4):397–423.
  25. Wisefaberowski L, Zhang H, Ing R, Pearlstein RD, Warner DS. Isoflurane-induced neuronal degeneration: An evaluation in organotypic hippocampal slice cultures. Anesth Analg. 2005;101(3):651–657.
  26. Liang G, Wang Q, Li Y, et al. A presenilin-1 mutation renders neurons vulnerable to isoflurane toxicity. Anesth Analg. 2008;106(2):492–500.
  27. Wei H, Kang BW, Liang G, Meng QC, Li Y, Eckenhoff RG. Isoflurane and sevoflurane affect cell survival and BCL-2/BAX ratio differently. Brain Res. 2005;1037(1–2):139–147.
  28. Jevtovic-Todorovic V, Hartman RE, Izumi Y, et al. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci. 2003;23(3):876–882.
  29. Yan H, Zhao H, Lee K-C, Wang H-Y, Zhang Y. Isoflurane increases neuronal cell death vulnerability by downregulating miR-214. PLoS One. 2013;8(2):e55276.
  30. Wang H, Xu Z, Feng C, et al. Changes of learning and memory in aged rats after isoflurane inhalational anaesthesia correlated with hippocampal acetylcholine level. Ann Fr Anesth Reanim. 2012;31(3):e61–66.
  31. Morris R, Morris R. Development of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods. 1984;11(1):47–60.
  32. Luo T, Yin S, Rong S, et al. miRNA expression profile and involvement of Let-7d-APP in aged rats with isoflurane-induced learning and memory impairment. PLoS One. 2015;10(3):e0119336.
  33. Abbasi E, Nassiriasl M, Sheikhi M, Shafiee M. Effects of vitexin on scopolamine-induced memory impairment in rats. Chin J Physiol. 2013;56(3):184–189.
  34. Li S, Hong M, Tan HY, Wang N, Feng Y. Insights into the role and interdependence of oxidative stress and inflammation in liver diseases. Oxid Med Cell Longev. 2016;2016:4234061.
  35. Min X, Cao FL, Zhang YF, et al. Tanshinone IIA therapeutically reduces LPS-induced acute lung injury by inhibiting inflammation and apoptosis in mice. Acta Pharmacol Sin. 2015;36(2):179–187.
  36. Yang ZB, Tan B, Li TB, et al. Protective effect of vitexin compound B-1 against hypoxia/reoxygenation-induced injury in differentiated PC-12 cells via NADPH oxidase inhibition. Naunyn Schmiedebergs Arch Pharmacol. 2014;387(9):861–871.
  37. Dong L, Fan Y, Shao X, Chen Z. Vitexin protects against myocardial ischemia/reperfusion injury in Langendorff-perfused rat hearts by attenuating inflammatory response and apoptosis. Food Chem Toxicol. 2011;49(12):3211–3216.
  38. Min JW, Hu JJ, He M, et al. Vitexin reduces hypoxia-ischemia neonatal brain injury by the inhibition of HIF-1alpha in a rat pup model. Neuropharmacology. 2015;99:38–50.
  39. Tong HX, Zhang JH, Ma L, Lu CW, Zhang JH. Role of caspase-8 and DR5 in TRAIL-induced apoptosis of neuroblastoma cells [in Chinese]. Zhongguo Dang Dai Er Ke Za Zhi. 2006;8(4):327–330.
  40. Corzo-Martínez M, Lebrón-Aguilar R, Villamiel M, Quintanilla-López JE, Moreno FJ. microRNA involvement in developmental and functional aspects of the nervous system and in neurological diseases. Neurosci Lett. 2009;466(2):55–62.
  41. Schratt G. Fine-tuning neural gene expression with microRNAs. Curr Opin Neurobiol. 2009;19(2):213–219.
  42. Persengiev S, Kondova I, Otting N, Koeppen AH, Bontrop RE. Genome-wide analysis of miRNA expression reveals a potential role for miR-144 in brain aging and spinocerebellar ataxia pathogenesis. Neurobiol Aging. 2011;32(12):2316.e2317–e2327.
  43. Cao L, Feng C, Li L, Zuo Z. Contribution of microRNA-203 to the isoflurane preconditioning-induced neuroprotection. Brain Res Bull. 2012;88(5):525–528.
  44. Anderson CN, Tolkovsky AM. A role for MAPK/ERK in sympathetic neuron survival: Protection against a p53-dependent, JNK-independent induction of apoptosis by cytosine arabinoside. J Neurosci. 1999;19(2):664–673.
  45. Yuan J, Yankner BA. Apoptosis in the nervous system. Nature. 2000;407(6805):802–809.
  46. Carling D, Thornton C, Woods A, Sanders MJ. AMP – activated protein kinase: New regulation, new roles? Biochem J. 2012;445(1):11–27.
  47. Kim YW, Jung EH, Byun SH, Sang CK, Cho IJ. Akebiae caulis extract inhibits oxidative stress through AMPK/GSK3-beta pathway (LB551). FASEB J. 2014;28.
  48. Lv H, Liu Q, Wen Z, Feng H, Deng X, Ci X. Xanthohumol ameliorates lipopolysaccharide (LPS)-induced acute lung injury via induction of AMPK/GSK3β-Nrf2 signal axis. Redox Biol. 2017;12:311–324.
  49. Wang L, Zhang S, Hang C, Lv H, Cheng G, Ci X. Nrf2-mediated liver protection by esculentoside A against acetaminophen toxicity through the AMPK/Akt/GSK3β pathway. Free Radic Biol Med. 2016;101:401–412.
  50. Lin CH, Yeh SH, Lin CH, et al. A role for the PI-3 kinase signaling pathway in fear conditioning and synaptic plasticity in the amygdala. Neuron. 2001;31(5):841–851.
  51. Su CY. Role of P-glycoprotein in pharmacokinetics and its clinical implications [in Chinese]. Yao Xue Xue Bao. 2005;40:673–679.